Phentolamine Ophthalmic Solution Vehicle (Placebo)

DRUG2 trials

Sponsors

Ocuphire Pharma, Inc.

Conditions

DilationDim Light Vision DisturbancesMydriasis

Phase 3

Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis

CompletedNCT04620213

Ocuphire Pharma, Inc.Dilation, Mydriasis

Start: 2020-11-18End: 2021-03-15Updated: 2023-09-11

Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) in Subjects With Dim Light Vision Disturbances

CompletedNCT04638660

Ocuphire Pharma, Inc.Dim Light Vision Disturbances

Start: 2020-12-30End: 2022-05-19Updated: 2025-10-14

Related Papers

A randomized phase 2 clinical trial of phentolamine mesylate eye drops in patients with severe night vision disturbances.

2022-10-083 citations